Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: TRVI) | Delayed: 12.61 -0.33 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.94 | 52 Week High | $ | |||
| Open | $12.74 | 52 Week Low | $ | |||
| Day High | $12.74 | P/E | N/A | |||
| Day Low | $12.39 | EPS | $ | |||
| Volume | 1,377,028 | |||||
